ZIABC011370 (ZIA) | |||
---|---|---|---|
Title | The Pathogenesis and Treatment of chronic GVHD | ||
Institution | NCI, Bethesda, MD | ||
Principal Investigator | Williams, Kirsten | NCI Program Director | N/A |
Cancer Activity | N/A | Division | CCR |
Funded Amount | $40,978 | Project Dates | 10/01/2010 - N/A |
Fiscal Year | 2012 | Project Type | Intramural |
Research Topics w/ Percent Relevance | Cancer Types w/ Percent Relevance | ||
Bone Marrow Transplantation (100.0%) Cancer (100.0%) Childhood Cancers (100.0%) Organ Transplantation Research (100.0%) |
Childhood Leukemia (100.0%) Leukemia (100.0%) |
||
Research Type | |||
Systemic Therapies - Discovery and Development Systemic Therapies - Clinical Applications |
|||
Abstract | |||
1) NIH BOS Montelukast trial (LAI): 22 patients enrolled to date, of which 19 patients have completed the primary endpoint. Interim analysis will be conducted this summer and analysis of immunological endpoints is ongoing. 2) FHCRC new onset BOS trial (chair): open at NIH, one patient accrued at NIH. 3) Lung consortium trial: in development. 4) cGVHD myositis study of respiratory muscle: manuscript has been published. 5) AI ON CGVHD Natural history study. Manuscript on PFT function equations is in submission. |